|
The effects of Furazabol are similar to
Winstrol except
instead of having an adverse effect on cholesterol
values, therapeutic doses of Furazabol purportedly
improve a person's blood lipid profile. As such,
Furazabol was prescribed in Japan under the trade
name Miotolan in the 1970s as a treatment for hypercholesterolemia.
Both Furazabol and Winstrol are modified
Dihydrotestosterone
(DHT) molecules; the former possesses a furazan
group and the latter a pyrazole group. This presumably
accounts for the different effects on blood lipids.
According to
William
Llewellyn, author of
Anabolics 2007, the cholesterol-lowering effects
of Furazabol are a myth. In the 1970s, research
studies showed that Furazabol along with many other
orally-active AAS like Anavar
(oxandrolone) lowered total serum cholesterol. It
was subsequently established that the cholesterol
reduction from oral AAS was the result of suppressed
HDL levels. As such, it would be expected that Furazabol,
like other oral anabolic steroids, while reducing
total cholesterol levels would still adversely affect
the HDL/LDL ratio and increase the risk of cardiovascular
disease.
Diversion of this obscure pharmaceutical steroid
to the black market rarely occurred while it was
being manufactured by Daiichi Seiyaku Company in
Japan. However, a number of underground labs (UGL)
have produced limited quantities of Furazabol in
recent years. Additionally, a non-methylated derivative
of Furazabol called
Furaguno is currently being sold over-the-counter
on the sport nutrition market in the United States
in 2006 and 2007.
The Canadian sprinter Ben Johnson tested positive
for Stanozolol after winning the gold medal in the
100 meter sprint at the 1988 Summer Olympics. His
doctor, Dr. Jamie Astaphan, maintains that his urine
sample was sabotaged because Johnson was administered
Furazabol which would have cleared his system well
in advance of the competition.
Furazabol is the chemical name of active
ingredient in Miotolan. Miotolan was
a registered trademark of Daiichi Seiyaku Co., Ltd
in Japan and/or other countries prior to cancellation.
|

|
| Substance
name |
Furazabol [INN]; Androfurazanol |
| Chemical
name |
17ß-hydroxy-17a-methyl-5a-androstano[2,3-c]-furazan |
| Systematic
name |
|
| Index name |
17-methyl-5 alpha-androstano(2,3-c)(1,2,5)oxadiazol-17
beta-ol |
| CAS number |
1239-29-8 |
| Molecular
formula |
C20-H30-N2-O2 |
| Molecular
weight |
330.469 g/mol |
| Legal Status |
Illegal (US);
DEA Schedule III (US) |
| Route of
Administration |
Intramuscular |
Visit Our Forums to Learn More About Anabolic Steroids
|